Gland-sparing neck dissection: oncological and functional outcomes in oral cancer patients
- PMID: 36517308
- DOI: 10.1016/j.ijom.2022.11.013
Gland-sparing neck dissection: oncological and functional outcomes in oral cancer patients
Abstract
This study was performed to evaluate the subjective and objective functional outcomes of patients who had undergone submandibular gland-sparing neck dissection. All data were obtained from patients treated in a single hospital. Seventy-seven patients who had undergone complete submandibular gland sparing (CSGS) were included in the study. Cancer prognosis items were recorded. The subjective outcomes included patient self-evaluation of mouth dryness and the evaluation of the presence of saliva secretion following the application of digital pressure. Saliva scintigraphy served as the objective test. Self-reported xerostomia was compared between the CSGS patients and a control group of patients who had undergone unilateral submandibular gland removal (USGR; n = 74). In the CSGS group, local recurrence occurred in 3.8% of the 80 cancer sites, and neck recurrence occurred in 5.9% of neck dissection sites. Regarding the subjective measurements, 7.0% of the CSGS patients reported xerostomia and 91.9% demonstrated saliva secretion by digital pressure. Scintigraphy revealed actively secreting glands, with 42.9% of them showing normal gland function; none of the patients had severe xerostomia. The relative risk of dry mouth was significantly higher in the USGR patients than in the CSGS patients (P < 0.001). Submandibular gland sparing during neck dissection was found to result in satisfactory saliva secretion, with a relatively small risk of local or neck recurrence.
Keywords: Mouth neoplasms; Neck dissection; Radionuclide imaging; Saliva; Submandibular gland.
Copyright © 2022 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Comment in
-
Response to the Letter to the Editor regarding "Gland-sparing neck dissection: oncological and functional outcomes in oral cancer patients".Int J Oral Maxillofac Surg. 2023 Oct;52(10):1107-1108. doi: 10.1016/j.ijom.2023.02.003. Epub 2023 Mar 1. Int J Oral Maxillofac Surg. 2023. PMID: 36868893 No abstract available.
-
Comment on "Gland-sparing neck dissection: oncological and functional outcomes in oral cancer patients".Int J Oral Maxillofac Surg. 2023 Oct;52(10):1106-1107. doi: 10.1016/j.ijom.2023.02.002. Epub 2023 Mar 3. Int J Oral Maxillofac Surg. 2023. PMID: 36872217 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical